PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
29,394,391
Share change
+1,255,163
Total reported value
$38,801,393
Put/Call ratio
0%
Price per share
$1.32
Number of holders
53
Value change
+$687,037
Number of buys
22
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q1 2022

As of 31 Mar 2022, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,394,391 shares. The largest 10 holders included NEA Management Company, LLC, Avidity Partners Management LP, RA CAPITAL MANAGEMENT, L.P., Rock Springs Capital Management LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, JOHNSON & JOHNSON, MAI Capital Management, Towercrest Capital Management, and Vericrest Private Wealth. This page lists 53 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.